semaglutides brands Semaglutide TrumpRx launches with 40 brand-name

More than 70% of patients taking GLP-1 medications reported reduced alcohol cravings, a decreased desire to drink, a reduction in how much alcohol they drink per week, fewer drinks per drinking session, and reduced binge drinking compared to prior to starting treatment compared to the control group that was not taking GLP-1 medications

LR3-IGF-1 bypasses the GH-axis and directly engages the IGF-1 receptor producing IGF-1-receptor effects without the broader pleiotropic GH effects

doi:10.1007/s13300-024-01674-8 Blumenthal RS, Morris PB, Gaudino M, et al

Experts have found that weight-loss injections that contain semaglutide can trigger the development of stomach paralysis, pancreatitis and bowel obstructions

Support a healthy immune system*